FRRS1L, ferric chelate reductase 1 like, 23732

N. diseases: 60; N. variants: 9
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37
0.600 GeneticVariation disease CLINVAR Loss-of-Function Mutations in FRRS1L Lead to an Epileptic-Dyskinetic Encephalopathy. 27236917 2016
CUI: C0085583
Disease: Choreoathetosis
Choreoathetosis
0.120 GeneticVariation disease BEFREE Loss-of-function mutations in a human AMPA receptor-associated protein, ferric chelate reductase 1-like (FRRS1L), are associated with a devastating neurological condition incorporating choreoathetosis, cognitive deficits and epileptic encephalopathies. 30692144 2019
CUI: C0085583
Disease: Choreoathetosis
Choreoathetosis
0.120 GeneticVariation disease BEFREE We describe a neurological disorder with epilepsy and prominent choreoathetosis caused by biallelic pathogenic variants in FRRS1L, which encodes an AMPA receptor outer-core protein. 27236917 2016
CUI: C0036857
Disease: Severe intellectual disability
Severe intellectual disability
0.110 GeneticVariation disease BEFREE Bi-allelic mutations in the human FRRS1L gene are shown to cause severe intellectual disability with cognitive impairment, speech delay and epileptic activity. 28675162 2017
CUI: C0014544
Disease: Epilepsy
Epilepsy
0.020 GeneticVariation disease BEFREE We describe a neurological disorder with epilepsy and prominent choreoathetosis caused by biallelic pathogenic variants in FRRS1L, which encodes an AMPA receptor outer-core protein. 27236917 2016
CUI: C0014544
Disease: Epilepsy
Epilepsy
0.020 GeneticVariation disease BEFREE Recent proteomic studies have identified that Ferric Chelate Reductase 1 Like protein (FRRS1L), whose mutations in human lead to epilepsy, choreoathetosis, and cognitive deficits, is present in native AMPAR complexes in the brain. 29276473 2017
CUI: C0085584
Disease: Encephalopathies
Encephalopathies
0.020 GeneticVariation group BEFREE Loss-of-function mutations in a human AMPA receptor-associated protein, ferric chelate reductase 1-like (FRRS1L), are associated with a devastating neurological condition incorporating choreoathetosis, cognitive deficits and epileptic encephalopathies. 30692144 2019
CUI: C0085584
Disease: Encephalopathies
Encephalopathies
0.020 GeneticVariation group BEFREE Loss-of-Function Mutations in FRRS1L Lead to an Epileptic-Dyskinetic Encephalopathy. 27236917 2016
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.020 GeneticVariation disease BEFREE Bi-allelic mutations in the human FRRS1L gene are shown to cause severe intellectual disability with cognitive impairment, speech delay and epileptic activity. 28675162 2017
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.020 GeneticVariation disease BEFREE Loss-of-function mutations in a human AMPA receptor-associated protein, ferric chelate reductase 1-like (FRRS1L), are associated with a devastating neurological condition incorporating choreoathetosis, cognitive deficits and epileptic encephalopathies. 30692144 2019
CUI: C0009241
Disease: Cognition Disorders
Cognition Disorders
0.010 GeneticVariation group BEFREE Loss-of-function mutations in a human AMPA receptor-associated protein, ferric chelate reductase 1-like (FRRS1L), are associated with a devastating neurological condition incorporating choreoathetosis, cognitive deficits and epileptic encephalopathies. 30692144 2019
CUI: C0241210
Disease: Speech Delay
Speech Delay
0.010 GeneticVariation disease BEFREE Bi-allelic mutations in the human FRRS1L gene are shown to cause severe intellectual disability with cognitive impairment, speech delay and epileptic activity. 28675162 2017
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37
0.600 Biomarker disease GENOMICS_ENGLAND Epileptic encephalopathy with continuous spike-and-wave during sleep maps to a homozygous truncating mutation in AMPA receptor component FRRS1L. 27239025 2016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37
0.600 Biomarker disease GENOMICS_ENGLAND Which genes to assess in the NGS diagnostics of intellectual disability? The case for a consensus database-driven and expert-curated approach. 30914295 2019
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37
0.600 Biomarker disease CTD_human
CUI: C0085583
Disease: Choreoathetosis
Choreoathetosis
0.120 Biomarker disease HPO
CUI: C0036857
Disease: Severe intellectual disability
Severe intellectual disability
0.110 Biomarker disease HPO
CUI: C0008489
Disease: Chorea
Chorea
0.100 Biomarker phenotype HPO
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 Biomarker disease HPO
CUI: C0013384
Disease: Dyskinetic syndrome
Dyskinetic syndrome
0.100 Biomarker disease HPO
CUI: C0013421
Disease: Dystonia
Dystonia
0.100 Biomarker phenotype HPO
CUI: C0021125
Disease: Impulsive Behavior
Impulsive Behavior
0.100 Biomarker phenotype HPO
CUI: C0025958
Disease: Microcephaly
Microcephaly
0.100 Biomarker disease HPO
CUI: C0026106
Disease: Mild Mental Retardation
Mild Mental Retardation
0.100 Biomarker disease HPO
CUI: C0026351
Disease: Moderate intellectual disability
Moderate intellectual disability
0.100 Biomarker disease HPO